Correlation Between NYSE Composite and Phoenix Biotech

Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Phoenix Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Phoenix Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NYSE Composite and Phoenix Biotech Acquisition, you can compare the effects of market volatilities on NYSE Composite and Phoenix Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Phoenix Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Phoenix Biotech.

Diversification Opportunities for NYSE Composite and Phoenix Biotech

0.0

Correlation Coefficient

NYSE Composite  Phoenix Biotech

Pay attention - limited upside

The 3 months correlation between NYSE and Phoenix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Phoenix Biotech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phoenix Biotech Acqu and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Phoenix Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phoenix Biotech Acqu has no effect on the direction of NYSE Composite i.e., NYSE Composite and Phoenix Biotech go up and down completely randomly.

Pair Corralation between NYSE Composite and Phoenix Biotech

If you would invest (100.00) in Phoenix Biotech Acquisition on December 5, 2024 and sell it today you would earn a total of  100.00  from holding Phoenix Biotech Acquisition or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

NYSE Composite  vs.  Phoenix Biotech Acquisition

Pair Trading with NYSE Composite and Phoenix Biotech

The main advantage of trading using opposite NYSE Composite and Phoenix Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Phoenix Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phoenix Biotech will offset losses from the drop in Phoenix Biotech's long position.

The idea behind NYSE Composite and Phoenix Biotech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.